Wells Fargo & Company Increases HCA Healthcare (NYSE:HCA) Price Target to $365.00

HCA Healthcare (NYSE:HCA) had its target price boosted by stock analysts at Wells Fargo & Company from $315.00 to $365.00 in a research note issued on Tuesday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price points to a potential upside of 0.54% from the stock’s current price.

A number of other brokerages also recently commented on HCA. Truist Financial lifted their target price on HCA Healthcare from $375.00 to $390.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Baird R W upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. JPMorgan Chase & Co. increased their price objective on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a report on Thursday, May 30th. SVB Leerink upped their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Finally, Robert W. Baird initiated coverage on HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price objective for the company. Four analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $344.06.

HCA Healthcare Stock Up 0.5 %

HCA stock opened at $363.05 on Tuesday. The company has a market capitalization of $95.09 billion, a P/E ratio of 18.10, a PEG ratio of 1.37 and a beta of 1.68. The firm has a 50 day simple moving average of $332.49 and a 200-day simple moving average of $324.10. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. HCA Healthcare has a twelve month low of $215.96 and a twelve month high of $366.10.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter last year, the company posted $4.29 earnings per share. The company’s quarterly revenue was up 10.3% compared to the same quarter last year. On average, equities research analysts predict that HCA Healthcare will post 22.43 earnings per share for the current fiscal year.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the business’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the sale, the executive vice president now owns 34,124 shares in the company, valued at approximately $10,544,316. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, EVP Michael S. Cuffe sold 1,600 shares of the firm’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $309.00, for a total value of $494,400.00. Following the completion of the sale, the executive vice president now owns 34,124 shares of the company’s stock, valued at $10,544,316. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Michael S. Cuffe sold 6,311 shares of the stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $316.88, for a total value of $1,999,829.68. Following the completion of the sale, the executive vice president now directly owns 29,624 shares of the company’s stock, valued at $9,387,253.12. The disclosure for this sale can be found here. Insiders sold a total of 20,268 shares of company stock valued at $6,804,285 over the last three months. Insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

Hedge funds have recently modified their holdings of the stock. Atlantic Edge Private Wealth Management LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter valued at about $27,000. Bangor Savings Bank grew its position in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares in the last quarter. MFA Wealth Advisors LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at $27,000. Unique Wealth Strategies LLC bought a new stake in HCA Healthcare in the second quarter worth $28,000. Finally, GPS Wealth Strategies Group LLC raised its holdings in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.